January has already seen impressive gains in broader markets, and shareholders in the Atlanta-based airline Delta (NYSE:DAL) stock have also enjoyed a year-to-date gain of about 6%. Source: VanderWolf Images/Shutterstock.com In the U.S, four major carriers — American Airlines (NASDAQ:AAL), United Continental Holdings (NASDAQ:UAL), Delta and Southwest Airlines (NYSE:LUV) — control about 70% of the domestic market. Furthermore,
0 Comments
Acasti Pharma (NASDAQ:ACST) is a classic example of the extreme volatility of small-cap biotech stocks. It was only in late December that the shares were fetching $2.87, up from $1 a year earlier. But now ACST stock is trading around 79 cents, with a market cap of about $70 million. To provide some context, in
0 Comments
David Tepper, founder of Appaloosa Management, said Friday he still likes this bull market, which is the longest on record.  ”I love riding a horse that’s running,” Tepper told CNBC’s Joe Kernen in an exclusive email. ”We have been long and continue that way.” The current bull market started in March of 2009. Since then, the S&P 500
0 Comments
This is a big deal. After all, one of the US Federal Reserve’s two major goals is to maintain the inflation rate near 2%.  Because, you know, high inflation is bad. If the inflation rate went up to 4, 5, or 6%, suddenly a lot of people would find themselves in the poor house.  Basically inflation
0 Comments
For a boring company like Cisco Systems (NASDAQ:CSCO), it enjoyed a solid performance in 2019. Last year, Cisco stock returned nearly 17% for stakeholders. Granted, it’s not an earth-shattering figure. As a telecommunications equipment specialist, Cisco isn’t exactly a sexy organization. However, it’s a name you may want to keep in the backburner. Source: Anucha
0 Comments
GW Pharmaceuticals PLC (GWPH) stocks rallied this week after the company released preliminary Q4 results that exceeded forecasts. The driving force behind the GWPH’s performance came from better-than-expected sales of the company’s flagship product Epidiolex, the cannabidiol (CBD)-based drug used to treat epilepsy, Lennox-Gastaut and Dravet syndromes.  Thus far, Epidiolex is the only CBD-based pharmaceutical
0 Comments
In this video we take stock chart requests from our members. ✅Join our 15 Minute “Going Live Alert” list (we hate spam too) https://thecontrariantrader.com/15-minute-live-stream-alert/ ✅Please Take Our 2 minute Survey- Help us understand your pain points with trading- Then we focus on them until they are resolved https://www.surveymonkey.com/r/HW3YH2W ✅Bob’s 5 Most Powerful Video Tutorial –
0 Comments
As the old adage puts it, the most dangerous words in investing are, “this time is different.” For years, that wisdom would have steered investors away from Plug Power (NASDAQ:PLUG) stock. Source: Shutterstock After all, Plug Power has been one of the market’s longest-running serial disappointers. Since inception, Plug Power has accumulated a deficit over
0 Comments
Shares of Chinese streaming giant iQiyi (NASDAQ:IQ) have gone parabolic over the past few months, rising from $15 in early October 2019 to $25 by early January 2020. That’s a jaw-dropping 65%-plus rally in IQ stock in just three months. Source: NYC Russ / Shutterstock.com What’s behind the recent strength in the company? More importantly,
0 Comments
Tonight on Thursday Night Stock Charts Live we discuss how we are poised to close out the trading week. We will do live technical analysis of the weekly stock charts. ✅Join our free Best Stock Charts Newsletter list (we hate spam too) http://eepurl.com/gsysiL ===================================================== ?Facebook Discussion Group Join Our Facebook Discussion Group! http://bit.ly/2k2TD2t ?Follow Me
0 Comments
In case you hadn’t noticed, America is having a delivery dilemma. What started out as a quaint thing called “shopping from home” has grown into perhaps the dominant industry of this generation. E-commerce is not only changing the way consumers shop, but it’s also changing how they spend their leisure time. And increasingly those consumers
0 Comments